[go: up one dir, main page]

NO20011502D0 - Fentanylsammensetning for behandling av akutt smerte - Google Patents

Fentanylsammensetning for behandling av akutt smerte

Info

Publication number
NO20011502D0
NO20011502D0 NO20011502A NO20011502A NO20011502D0 NO 20011502 D0 NO20011502 D0 NO 20011502D0 NO 20011502 A NO20011502 A NO 20011502A NO 20011502 A NO20011502 A NO 20011502A NO 20011502 D0 NO20011502 D0 NO 20011502D0
Authority
NO
Norway
Prior art keywords
composition
treatment
acute pain
fentanyl
essentially water
Prior art date
Application number
NO20011502A
Other languages
English (en)
Other versions
NO332228B1 (no
NO20011502L (no
Inventor
Anders Petterson
Christer Nystroem
Hans Lennernos
Bo Lennernos
Thomas Hedner
Original Assignee
Diabact Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20412701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011502(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diabact Ab filed Critical Diabact Ab
Publication of NO20011502D0 publication Critical patent/NO20011502D0/no
Publication of NO20011502L publication Critical patent/NO20011502L/no
Publication of NO332228B1 publication Critical patent/NO332228B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20011502A 1998-09-24 2001-03-23 Farmasoytisk sammensetning inneholdende fentanyl for behandling av akutt smerte, samt anvendelse av fentanyl for fremstilling av en farmasoytisk sammensetning. NO332228B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain
PCT/SE1999/001688 WO2000016751A1 (en) 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain

Publications (3)

Publication Number Publication Date
NO20011502D0 true NO20011502D0 (no) 2001-03-23
NO20011502L NO20011502L (no) 2001-03-23
NO332228B1 NO332228B1 (no) 2012-07-30

Family

ID=20412701

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011502A NO332228B1 (no) 1998-09-24 2001-03-23 Farmasoytisk sammensetning inneholdende fentanyl for behandling av akutt smerte, samt anvendelse av fentanyl for fremstilling av en farmasoytisk sammensetning.

Country Status (26)

Country Link
US (1) US6759059B1 (no)
EP (1) EP1115384B1 (no)
JP (2) JP2002526440A (no)
KR (1) KR100760531B1 (no)
CN (1) CN1170524C (no)
AT (1) ATE247950T1 (no)
AU (1) AU764473B2 (no)
BG (1) BG65363B1 (no)
BR (1) BR9913948B1 (no)
CA (1) CA2345064C (no)
CZ (1) CZ301562B6 (no)
DE (1) DE69910803T2 (no)
DK (1) DK1115384T3 (no)
EE (1) EE200100176A (no)
ES (1) ES2207295T3 (no)
HU (2) HU228992B1 (no)
IL (2) IL142126A0 (no)
NO (1) NO332228B1 (no)
NZ (1) NZ510646A (no)
PL (1) PL197078B1 (no)
PT (1) PT1115384E (no)
RU (1) RU2232580C2 (no)
SE (1) SE9803239D0 (no)
SK (1) SK283503B6 (no)
TR (1) TR200100812T2 (no)
WO (1) WO2000016751A1 (no)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
KR100888275B1 (ko) 2000-07-31 2009-03-10 니코메드 댄마크 에이에스 코 투여용 펜타닐 조성물
HU230875B1 (hu) 2000-10-30 2018-11-29 Euro-Celtique S.A. Szabályozott hatóanyag-leadású hidrokodon készítmények
US20030003113A1 (en) * 2001-06-29 2003-01-02 Lewandowski Leon J. Individualized addiction cessation therapy
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
ES2284783T3 (es) * 2001-11-16 2007-11-16 Randox Laboratories Ltd. Metodo y estuche para detectar, o determinar la cantidad de,metabolitos de fentanilo y metabolitos de analogos de fentanilo.
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN100581586C (zh) * 2003-01-31 2010-01-20 奥雷克索公司 一种快速起效的药物组合物
MXPA05009602A (es) * 2003-03-11 2005-11-08 Arakis Ltd Composiciones novedosas.
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
KR101184138B1 (ko) 2003-12-31 2012-09-19 시마 랩스 인크. 일반적인 선형 발포성 경구 펜타닐 투약 제형 및 투여 방법
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
MXPA06007453A (es) * 2003-12-31 2007-01-31 Cima Labs Inc Forma de dosificacion de opiaceo oral efervescente.
JP5179757B2 (ja) * 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP1863456A1 (en) * 2005-03-28 2007-12-12 Orexo AB New pharmaceutical compositions useful in the treatment of pain
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
AU2006326377B2 (en) * 2005-12-13 2010-10-07 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
PL1976521T3 (pl) 2006-01-25 2015-10-30 Insys Therapeutics Inc Spray fentanylu do podawania podjęzykowego
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20080090874A1 (en) * 2006-09-20 2008-04-17 Messina John C Jr Treatment of breakthrough pain in patients suffering from chronic low back pain
FR2907680B1 (fr) * 2006-10-27 2012-12-28 Scras Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
ES2439581T3 (es) * 2006-12-04 2014-01-23 Orexo Ab Nueva composición farmacéutica no susceptible de abuso que comprende opioides
WO2008100434A1 (en) 2007-02-09 2008-08-21 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US20080287494A1 (en) * 2007-04-24 2008-11-20 Cephalon, Inc. Transmucosal treatment methods in patients with mucositis
WO2008148734A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
NO2180844T3 (no) 2007-08-02 2018-07-21
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2295046B1 (de) * 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
EP3064064A1 (en) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CA2777218C (en) 2009-10-30 2016-09-27 Ix Biopharma Pte Ltd Fast dissolving solid dosage form
WO2011143120A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholres i stant metoprolol - containing extended - release oral dosage forms
US20120183580A1 (en) * 2011-01-13 2012-07-19 Theralpha Analgesic Composition for Transbuccal Administration
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
RS53995B1 (sr) 2011-09-19 2015-10-30 Orexo Ab Nove farmaceutske kompozicije, otporne na zloupotrebu, za tretman zavisnosti od opioida
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
DE102012006396A1 (de) 2012-03-29 2013-10-02 Willy Rüsch GmbH Tracheostomietubus
LT2849730T (lt) 2012-05-02 2016-12-27 Orexo Ab Nauja alfentanilo kompozicija, skirta ūmaus skausmo gydymui
EP2925304B1 (en) 2012-11-30 2018-09-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
CA2888219C (en) * 2014-02-07 2018-07-10 Scilabs Pharmaceuticals, Inc. All natural, non-toxic sublingual drug delivery systems
WO2016086095A1 (en) 2014-11-25 2016-06-02 Biodelivery Sciences International, Inc. Patches, methods for forming and testing pharmaceutical agent delivery patches
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action

Also Published As

Publication number Publication date
HU230688B1 (hu) 2017-09-28
JP4478512B2 (ja) 2010-06-09
CN1328448A (zh) 2001-12-26
WO2000016751A1 (en) 2000-03-30
DK1115384T3 (da) 2003-12-22
EP1115384B1 (en) 2003-08-27
TR200100812T2 (tr) 2001-07-23
BG105380A (en) 2001-12-29
CA2345064A1 (en) 2000-03-30
PT1115384E (pt) 2004-01-30
PL347467A1 (en) 2002-04-08
IL142126A (en) 2006-04-10
JP2002526440A (ja) 2002-08-20
HU228992B1 (en) 2013-07-29
JP2004269545A (ja) 2004-09-30
NZ510646A (en) 2004-04-30
CZ20011030A3 (cs) 2001-09-12
SE9803239D0 (sv) 1998-09-24
BR9913948B1 (pt) 2011-02-08
HUP0103621A2 (hu) 2002-02-28
EE200100176A (et) 2002-08-15
DE69910803T2 (de) 2004-06-17
CN1170524C (zh) 2004-10-13
ATE247950T1 (de) 2003-09-15
AU764473B2 (en) 2003-08-21
SK283503B6 (sk) 2003-08-05
DE69910803D1 (de) 2003-10-02
EP1115384A1 (en) 2001-07-18
PL197078B1 (pl) 2008-02-29
BG65363B1 (bg) 2008-04-30
HUP0103621A3 (en) 2005-05-30
AU6492899A (en) 2000-04-10
NO332228B1 (no) 2012-07-30
US6759059B1 (en) 2004-07-06
ES2207295T3 (es) 2004-05-16
SK4012001A3 (en) 2001-10-08
RU2232580C2 (ru) 2004-07-20
BR9913948A (pt) 2001-06-12
KR100760531B1 (ko) 2007-10-04
CZ301562B6 (cs) 2010-04-14
KR20010075314A (ko) 2001-08-09
NO20011502L (no) 2001-03-23
IL142126A0 (en) 2002-03-10
CA2345064C (en) 2008-05-27

Similar Documents

Publication Publication Date Title
NO20011502L (no) Fentanylsammensetning for behandling av akutt smerte
MXPA01003068A (es) Composicion farmaceutica para el tratamiento de alteraciones agudas.
DK1587514T3 (da) Hurtigvirkende farmaceutisk præparat
DE69803360D1 (de) Anwendungsformen zur behandlung der männlichen erektilen dysfunktion
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
BR0315482A (pt) Composições farmacêuticas e formas de dosagem para liberações bucal e sublingual da tizanidina e métodos de administração da tizanidina de forma sublingual ou bucal
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення

Legal Events

Date Code Title Description
MK1K Patent expired